We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
78 hedge funds and large institutions have $101M invested in State Street SPDR S&P Pharmaceuticals ETF in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.81% more ownership
Funds ownership: 41.66% → 43.47% (+1.8%)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
1% less funds holding
Funds holding: 79 → 78 (-1)
10% less capital invested
Capital invested by funds: $112M → $101M (-$11.1M)
55% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 31
Holders
78
Holders Change
-1
Holders Change %
-1.27%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
31
Closed
9
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$344K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$8.99M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.25M |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$719K |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$565K |
| 5 |
IMC Chicago
Chicago,
Illinois
|
+$552K |
Top Sellers
| 1 |
CI
CX Institutional
Auburn,
Indiana
|
-$2.12M |
| 2 |
FCM
Fortis Capital Management
Bellevue,
Washington
|
-$2.07M |
| 3 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$1.65M |
| 4 |
JP Morgan Chase
New York
|
-$1.47M |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
-$1.35M |
